Navigation Links
ReVision's Fenretinide (RT-101) Reduced Incidence of Choroidal Neovascularization by More Than 50 Percent in Patients With Geographic Atrophy in a Phase 2b Trial
Date:9/1/2010

rapeuticsReVision Therapeutics Inc. is an ophthalmic biopharmaceutical company developing a novel small molecule drug for the treatment and prevention of the dry form of age-related macular degeneration (AMD). Fenretinide (RT-101), ReVision's lead drug candidate, has been evaluated in a Phase 2b clinical trial in patients with geographic atrophy, the most advanced form of dry AMD. Analysis of the end-of-study data is ongoing. AMD is the leading cause of blindness in the elderly, and there are currently no treatments for the dry form of AMD, which accounts for 90 percent of patients with the disease. AMD gradually destroys sharp, central vision, and is caused by the accumulation of A2E, a toxic byproduct of the visual cycle, in the retina. Fenretinide reduces A2E accumulation in the retina by reducing systemic levels of retinol (vitamin A), a precursor to A2E. ReVision was founded in 2010 with corporate headquarters in San Diego, California. For more information, visit www.revisiontherapeutics.comMedia ContactHeidi Chokeir, Ph.D.Russo Partners, LLCP (619)528-2217M (858)380-6584heidi.chokeir@russopartnersllc.com
'/>"/>
SOURCE ReVision Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH
2. Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008
3. Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
4. Cord Blood America Says Debt Reduced $4.194 Million in 2009
5. Reorganizational Healing Provides Access to Greater Quality of Life, Reduced Stress
6. China Yongxin Pharmaceuticals Projects Higher Net Income and EPS on Reduced Revenue for Full-Year 2009
7. The toxicity of antimicrobial silver in products can be reduced
8. Orexigen(R) Therapeutics Announces That Contrave(R) Reduced Depression Scores and Body Weight in Overweight and Obese Patients With Major Depression
9. Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients
10. Retrospective Analysis of Phase 3 Data Suggest Wyeths Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
11. Half of Surveyed Physicians Expect to Replace Between 6 Percent and 15 Percent of Their Sustiva Prescriptions with Isentress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... March 31, 2015  Bayer HealthCare (Bayer) has ... Massachusetts Institute of Technology (MIT) and Harvard University ... goal of this new part of the alliance ... help create new cardiovascular therapies. "We ... Broad Institute to the area of cardiovascular genomics ...
(Date:3/31/2015)... and NEW YORK , ... PTBI ), a biopharmaceutical company advancing protein ... today that its Korean marketing partner, Hanmi Pharmaceutical ... approval in Korea from the country,s Ministry of ... Testing & Research Institute (KTR) for MuGard, its ...
(Date:3/31/2015)... Today, Cryos International, the world’s largest international ... facilities and inventory from New York City to Orlando, ... relocation is a reflection of their increasing growth and ... completed during the first weekend of spring, March 21 ... April 6. The new facility in the Central Florida ...
(Date:3/30/2015)... San Francisco, CA (PRWEB) March 30, 2015 ... and tax incentives provided you the government, major companies ... state and local governments setting future mandates for renewable ... power as an option. , Solara Power is a ... to several incentive programs available that allow qualifying homeowners ...
Breaking Biology Technology:Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease 2Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease 3PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3Cryos International Completes Groundbreaking Sperm Migration to Orlando, Florida 2Solara Power Announces Residential Solar Power with No Up-Front Fees 2
... the complexities of the biotech industry to investors, academics and start-up ... painstaking and expensive process. What they don't understand is why. ... shows us the following pathway: , , , ,Logical questions ... patent life of a drug is 20 years and it takes ...
... of talk about customers. Calling on customers. Securing first ... years of loose talk about brand building that somehow ... brand reputation as much as the vendor does. Indeed, ... incredible software companies, customers never really went out of ...
... vendors and partners feel good about doing business and ... and co-founder of Inacom Information Systems , a ... ,Benson and Inacom were recently recognized and awarded the ... second year in a row. According to Ingram Micro, ...
Cached Biology Technology:The Complexities, Cost of Midwest Biotech Drug Development 2The Complexities, Cost of Midwest Biotech Drug Development 3The Complexities, Cost of Midwest Biotech Drug Development 4The Secret of Success: Listen To Customers 2The Secret of Success: Listen To Customers 3Inacoms Benson Receives Top Industry Recognition 2Inacoms Benson Receives Top Industry Recognition 3
(Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/4stcg3/india_sensors ) ... Sensors Market Forecast and Opportunities 2020" report ... is projected to grow at a CAGR over ... industrial and healthcare sectors are the key application ... adoption of MEMS technology in sensors is growing ...
(Date:3/19/2015)... 19, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... that aired this week on Washington DC,s ... In a segment "The Next Great Thing", host Laura ... to pay, and ,a really big breakthrough in mobile payment.,  ...
(Date:3/17/2015)... YORK , March 17, 2015  MecklerMedia ... the largest exhibition for service robots ever held ... RoboUniverse takes place on May 11-13, 2015 at ... and exhibitors for the event include: Acorn Product ... Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... tummy,s taste for red wine with red meat , ... when red wine meets red meat? If the rendezvous happens ... of healthful chemical compounds may thwart formation of harmful substances ... which reinforces the benefits of consuming wine and other foods ...
... at Chicago have identified a novel function for an enzyme ... respiratory distress syndrome, also known as ARDS. The finding ... of lung inflammation and injury. The research will be published ... and online June 29. ARDS is an often fatal ...
... times larger than their wild relatives. How did they ... larger fruits, heads of grain, tubers, etc, because this is ... for food. In addition to size, tomatoes have been ... it has been difficult to study these traits in tomatoes, ...
Cached Biology News:American Chemical Society's Weekly PressPac -- June 25, 2008 2American Chemical Society's Weekly PressPac -- June 25, 2008 3American Chemical Society's Weekly PressPac -- June 25, 2008 4American Chemical Society's Weekly PressPac -- June 25, 2008 5American Chemical Society's Weekly PressPac -- June 25, 2008 6American Chemical Society's Weekly PressPac -- June 25, 2008 7American Chemical Society's Weekly PressPac -- June 25, 2008 8American Chemical Society's Weekly PressPac -- June 25, 2008 9UIC researchers make promising finding in severe lung disease 2Evolution of fruit size in tomato 2Evolution of fruit size in tomato 3
Recommended for use as a cell culture substratum at 0.1-0.2 mg/cm 2 or 5-10 μl/cm 2 . Optimal concentration depends on cell type as well as the application or research objectives. Type B...
... is a state-of-the-art separation system using the ... The Eclipse integrates easily with Wyatts multi-angle ... as well as the Optilab DSP. The ... mass distributions of the particles/molecules separated by ...
... A three-color reagent kit for determining ... human peripheral blood samples, mobilized peripheral blood ... also provide a total nucleated cell count ... This kit is designed for use in ...
... IgM binds poorly to Protein A and, until ... for one- step IgM purification. Standard methods for ... they are not effective for removing all of ... Pierce has developed an ...
Biology Products: